1. KETs Biotec, Nanotechnologies and Advanced Materials
EU-IRAN HIGHER EDUCATION AND RESEARCH EVENT Tehran, Islamic Republic of Iran 3rd July 2017
Carmine Marzano DG Research and Innovation European Commission

2. LEIT Biotechnology:
Developing technological solutions for Industrial biotechnology
Main lines:
Biotechnology-based industrial processes, including environmental and health biotechnology
Boosting cutting-edge biotechnologies as future innovation drivers
Innovative and competitive platform technologies

3. Outline of potential opportunities in the Biotechnology area WP 2018-20:
Synthetic Biology
Environmental bioremediation technologies
Biodegradation of plastics
Biosensor development
Multi-omics technologies

4. KET Nanotechnology:
Harness the potential of nanotechnologies in a safe and secure way
Main lines:
Nanosafety (regulation and risk assessment)
Highly cross-cutting and multidisciplinary KET, closely interlinked to the other KETs advanced materials, advanced manufacturing, space, photonics, etc.

5. Outline of potential opportunities in the Nanotechnology area WP 2018-20:
Nanoinformatics (predictive toxicology and ecotoxicology)
Safety by design applied to the nanotechnology domain
Regulations for nanotechnology applied to the medical field

6. KET Advanced Materials:
Developing the next generation of Materials, closely linked to the KET nanotechnology
Main lines:
Materials characterisation and modelling
Materials for energy and processing
Materials for medical applications

7. Outline of potential opportunities in the Materials area WP 2018-20
Characterisation technologies for (nano)materials
Modelling technologies for advanced materials
Organs on chip and materials for tissue regeneration
Battery technologies
Materials for photovoltaic applications
Energy harvesting materials

8. Particular interest for 2018: Hydrocarbon conversion technologies
Interesting for the development of technologies for the valorisation of light hydrocarbons (e.g. Methane).
Suitable for the development of technologies to tackle flaring or processing natural gas into higher hydrocarbon (e.g. olefins).
International cooperation encouraged
Examples of projects:

9. 2018 Call details (tentative)
2 stage evaluations:
Calls’ opening: 31st Oct 2017
Tentative deadlines:
1st Stage: 23 Jan 2018 (short proposals)
2nd Stage: 4th July 2018 (full proposals, if invited)

10. Thank you for your attention!
Contact:
Look for results of European research:

11. Application of the Technology Readiness Levels
Where a topic description refers to a TRL, the following definitions apply, unless otherwise specified:
- TRL 1 – basic principles observed
- TRL 2 – technology concept formulated
- TRL 3 – experimental proof of concept
- TRL 4 – technology validated in lab
- TRL 5 – technology validated in relevant environment (industrially relevant environment in the case of key -enabling technologies)
- TRL 6 – technology demonstrated in relevant environment (industrially relevant environment in the case of key enabling technologies)
- TRL 7 – system prototype demonstration in operational environment
- TRL 8 – system complete and qualified
- TRL 9 – actual system proven in operational environment (competitive manufacturing in the case of key enabling technologies; or in space)

12. Horizon 2020: Types of action
(see the general annex for further information)
Research and Innovation Actions (RIA)
Activities aiming to establish new knowledge and/or to explore the feasibility of a new or improved technology, product, process, service or solution.
They may include basic and applied research, technology development and integration, testing and validation on a small-scale prototype in a laboratory or simulated environment.
Projects may contain closely connected but limited demonstration or pilot activities aiming to show technical feasibility in a near to operational environment.
Funding rate: 100%
Innovation Actions (IA)
Activities directly aiming at producing plans and arrangements or designs for new, altered or improved products, processes or services. They may include prototyping, testing, demonstrating, piloting, large-scale product validation and market replication.
Funding rate: 70% (except for non-profit legal entities, where a rate of 100% applies)
Coordination and support actions (CSA)
Actions consisting primarily of accompanying measures such as standardisation, dissemination, awareness-raising and communication, networking, coordination or support services, policy dialogues and mutual learning exercises and studies, including design studies for new infrastructure and may also include complementary activities of strategic planning, networking and coordination between programmes in different countries.

13. More information: Nanotechnology KET:
Advanced Materials:
s/materials_en.html
Biotechnologies:
s/biotechnologies_en.html

14. Biotechnology-based industrial processes driving competitiveness and sustainability
Aim: Maintain European leadership in industrial and environmental biotechnology.
Biocatalysts and bio-processing: bioprospecting, optimization of biocatalysts and biocatalytic process design
Novel and improved microorganisms: understanding gene expression in the light of stress conditions; understanding mixed cultures and the dynamics of microbial communities
Bioreactors and downstream processing: address possible bottlenecks in downstream processing and facilitate the transfer of new developments into operational environments
Environmental biotechnology: focussing on the development and practical use of know-how in terms of bioprospecting; biodetection of environmental pollution; bioremediation

15. Cutting-edge biotechnologies as future innovation drivers
Aim: Assuring that the European industry stays at the forefront of innovation, also in the medium and long term
Synthetic biology: creation of minimal cells, design of robust and sustainable bio-molecular circuits and pathways, biosafety and bioethics
Systems biology: investigating the operations of biological systems in order to optimize industrial applications of biotechnology
Bioinformatics: provision of powerful tools to store, retrieve and analyse biological data, in support of modelling and process design
Nano-biotechnology: combining both fields of research for application development in a wide range of sectors, biosafety and bioethics
Biotechnology in ICT: provision of ICT-devices incorporating biological materials

16. Innovative and competitive platform technologies
Aim: Develop platform biotechnologies for a wide range of sectors to support European industrial leadership.
Platform technologies: Development of platform technologies and their integration across applications in support of the commercial use of biotechnology
Industrial applications of 'omics': Bringing closer to the market 'omics'-derived industrial applications, including prototyping and demonstration